{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:25:40Z","timestamp":1794889540039,"version":"4.9.1"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,4,25]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Optimal transfusion strategies in traumatic hemorrhage are unknown. Reports suggest a beneficial effect of 4-factor prothrombin complex concentrate (4F-PCC) on blood product consumption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the efficacy and safety of 4F-PCC administration in patients at risk of massive transfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Double-blind, randomized, placebo-controlled superiority trial in 12 French designated level I trauma centers from December 29, 2017, to August 31, 2021, involving consecutive patients with trauma at risk of massive transfusion. Follow-up was completed on August 31, 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Intravenous administration of 1 mL\/kg of 4F-PCC (25 IU of factor IX\/kg) vs 1 mL\/kg of saline solution (placebo). Patients, investigators, and data analysts were blinded to treatment assignment. All patients received early ratio-based transfusion (packed red blood cells:fresh frozen plasma ratio of 1:1 to 2:1) and were treated according to European traumatic hemorrhage guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was 24-hour all blood product consumption (efficacy); arterial or venous thromboembolic events were a secondary outcome (safety).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 4313 patients with the highest trauma level activation, 350 were eligible for emergency inclusion, 327 were randomized, and 324 were analyzed (164 in the 4F-PCC group and 160 in the placebo group). The median (IQR) age of participants was 39 (27-56) years, Injury Severity Score was 36 (26-50 [major trauma]), and admission blood lactate level was 4.6 (2.8-7.4) mmol\/L; prehospital arterial systolic blood pressure was less than 90 mm Hg in 179 of 324 patients (59%), 233 patients (73%) were men, and 226 (69%) required expedient hemorrhage control. There was no statistically or clinically significant between-group difference in median (IQR) total 24-hour blood product consumption (12 [5-19] U in the 4F-PCC group vs 11 [6-19] U in the placebo group; absolute difference, 0.2 U [95% CI, \u22122.99 to 3.33];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.72). In the 4F-PCC group, 56 patients (35%) presented with at least 1 thromboembolic event vs 37 patients (24%) in the placebo group (absolute difference, 11% [95% CI, 1%-21%]; relative risk, 1.48 [95% CI, 1.04-2.10];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Among patients with trauma at risk of massive transfusion, there was no significant reduction of 24-hour blood product consumption after administration of 4F-PCC, but thromboembolic events were more common. These findings do not support systematic use of 4F-PCC in patients at risk of massive transfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03218722\">NCT03218722<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2023.4080","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T04:01:03Z","timestamp":1679371263000},"page":"1367","source":"Crossref","is-referenced-by-count":126,"title":["Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion"],"prefix":"10.1001","volume":"329","author":[{"given":"Pierre","family":"Bouzat","sequence":"first","affiliation":[{"name":"Universit\u00e9 Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institute Neurosciences, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Charbit","sequence":"additional","affiliation":[{"name":"Trauma Critical Care Unit, Montpellier University Hospital, F-34295 Montpellier Cedex 5, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paer-Selim","family":"Abback","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Beaujon Hospital, DMU Parabol, AP-HP. Nord, Clichy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Huet-Garrigue","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Centre Hospitalier Universitaire Lille, Surgical Critical Care, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Delhaye","sequence":"additional","affiliation":[{"name":"AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Universit\u00e9, site Piti\u00e9-Salp\u00eatri\u00e8re, D\u00e9partement d\u2019Anesth\u00e9sie R\u00e9animation, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Leone","sequence":"additional","affiliation":[{"name":"Aix Marseille University, Assistance Publique H\u00f4pitaux Universitaires de Marseille, Department of Anesthesiology and Intensive Care Unit, North Hospital, and Centre for CardioVascular and Nutrition Research (C2VN), Inserm 1263, Inrae 1260, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Marcotte","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Hopital Edouard Herriot, Department of Anesthesia and Intensive Care, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-St\u00e9phane","family":"David","sequence":"additional","affiliation":[{"name":"University Claude Bernard Lyon 1, INSERM U1290, Research on Healthcare Performance (RESHAPE), and Hospices Civils de Lyon, Groupement Hospitalier Sud, Department of Anesthesia and Intensive Care, Pierre Benite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrice","family":"Levrat","sequence":"additional","affiliation":[{"name":"Intensive care unit, Annecy Hospital, Annecy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Asehnoune","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Nantes, CHU Nantes, P\u00f4le anesth\u00e9sie r\u00e9animations, Service d'Anesth\u00e9sie R\u00e9animation chirurgicale, H\u00f4tel Dieu, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Pottecher","sequence":"additional","affiliation":[{"name":"H\u00f4pitaux Universitaires de Strasbourg, H\u00f4pital de Hautepierre, Service d\u2019Anesth\u00e9sie-R\u00e9animation & M\u00e9decine P\u00e9ri-Op\u00e9ratoire - Universit\u00e9 de Strasbourg, Facult\u00e9 de M\u00e9decine, FMTS, ER3072, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Duranteau","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, H\u00f4pitaux Universitaires Paris Sud, Universit\u00e9 Paris XI, Facult\u00e9 de M\u00e9decine Paris-Sud, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Courvalin","sequence":"additional","affiliation":[{"name":"Trauma Critical Care Unit, Montpellier University Hospital, F-34295 Montpellier Cedex 5, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Adolle","sequence":"additional","affiliation":[{"name":"P\u00f4le d\u2019Anesth\u00e9sie-R\u00e9animation, CHU Grenoble Alpes, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Sourd","sequence":"additional","affiliation":[{"name":"Univ. Grenoble Alpes, CNRS, Public Health department CHU Grenoble Alpes, TIMC-IMAG, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Bosson","sequence":"additional","affiliation":[{"name":"Univ. Grenoble Alpes, CNRS, Public Health department CHU Grenoble Alpes, TIMC-IMAG, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Riou","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, UMR-S INSERM 1166, IHU ICAN, and Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Department of Emergency medicine and Surgery, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Gauss","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Beaujon Hospital, DMU Parabol, AP-HP. Nord, Clichy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Payen","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institute Neurosciences, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PROCOAG Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Greze","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Banco","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Berger","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Druge","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dupuis","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Janin","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Machuron","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Thomas","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Schilte","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Hamad","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Zieleskiewicz","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Duclos","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Arbelot","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Bezulier","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Jeantrelle","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Raux","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Glasman","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatole","family":"Harrois","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Tarazona","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Lambert","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Vassal","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Li","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Grillot","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efs","family":"Henry","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Blonde","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bijok","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Rohn","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bellet","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lallemant","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bruneau","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ducam","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Dagod","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Deras","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Capdevila","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Szczot","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Meyer","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Hecketsweiler","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Escudier","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Muller","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Gray","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Farines","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lebouc","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"DEBORD-PEDET","sequence":"additional","affiliation":[{"name":"for the PROCOAG Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"joi230034r1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.injury.2016.10.037","article-title":"Trends in 1029 trauma deaths at a level 1 trauma center: impact of a bleeding control bundle of care.","volume":"48","author":"Oyeniyi","year":"2017","journal-title":"Injury"},{"issue":"3","key":"joi230034r2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/SLA.0000000000004563","article-title":"Evidence-based and clinically relevant outcomes for hemorrhage control trauma trials.","volume":"273","author":"Holcomb","year":"2021","journal-title":"Ann Surg"},{"issue":"6","key":"joi230034r3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/SLA.0000000000003657","article-title":"A decade of damage control resuscitation: new transfusion practice, new survivors, new directions.","volume":"273","author":"Cole","year":"2021","journal-title":"Ann Surg"},{"issue":"6","key":"joi230034r4","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1007\/s00068-022-01998-9","article-title":"The conundrum of the definition of haemorrhagic shock: a pragmatic exploration based on a scoping review, experts\u2019 survey and a cohort analysis.","volume":"48","author":"James","year":"2022","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"4","key":"joi230034r5","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1016\/S2352-3026(22)00040-0","article-title":"Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial.","volume":"9","author":"Crombie","year":"2022","journal-title":"Lancet Haematol"},{"issue":"5","key":"joi230034r6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"joi230034r7","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","article-title":"Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial.","volume":"4","author":"Innerhofer","year":"2017","journal-title":"Lancet Haematol"},{"issue":"1","key":"joi230034r8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00134-020-06266-1","article-title":"Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial.","volume":"47","author":"Baksaas-Aasen","year":"2021","journal-title":"Intensive Care Med"},{"issue":"2","key":"joi230034r9","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1186\/cc8948","article-title":"Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.","volume":"14","author":"Sch\u00f6chl","year":"2010","journal-title":"Crit Care"},{"issue":"2","key":"joi230034r10","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/cc10078","article-title":"Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.","volume":"15","author":"Sch\u00f6chl","year":"2011","journal-title":"Crit Care"},{"issue":"1","key":"joi230034r11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/TA.0000000000001938","article-title":"The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: a propensity matched analysis.","volume":"85","author":"Jehan","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"joi230034r12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/TA.0000000000002262","article-title":"Four-factor prothrombin complex concentrate is associated with improved survival in trauma-related hemorrhage: A nationwide propensity-matched analysis.","volume":"87","author":"Zeeshan","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"joi230034r13","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s13063-021-05524-x","article-title":"Four-factor prothrombin complex concentrate to reduce allogenic blood product transfusion in patients with major trauma, the PROCOAG trial: study protocol for a randomized multicenter double-blind superiority study.","volume":"22","author":"Bouzat","year":"2021","journal-title":"Trials"},{"issue":"1","key":"joi230034r14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13054-015-0835-7","article-title":"A regional trauma system to optimize the pre-hospital triage of trauma patients.","volume":"19","author":"Bouzat","year":"2015","journal-title":"Crit Care"},{"issue":"2","key":"joi230034r15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/TA.0b013e3181961c35","article-title":"Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)?","volume":"66","author":"Nunez","year":"2009","journal-title":"J Trauma"},{"issue":"9","key":"joi230034r16","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/j.1538-7836.2010.03945.x","article-title":"Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations.","volume":"8","author":"Frith","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"6","key":"joi230034r17","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1097\/SLA.0000000000002825","article-title":"Data-driven development of ROTEM and TEG algorithms for the management of trauma hemorrhage: a prospective observational multicenter study.","volume":"270","author":"Baksaas-Aasen","year":"2019","journal-title":"Ann Surg"},{"issue":"9771","key":"joi230034r18","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0140-6736(11)60278-X","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.","volume":"377","author":"Roberts","year":"2011","journal-title":"Lancet"},{"key":"joi230034r19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13054-016-1265-x","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition.","volume":"20","author":"Rossaint","year":"2016","journal-title":"Crit Care"},{"issue":"1","key":"joi230034r20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13049-018-0523-0","article-title":"Modelling the association between fibrinogen concentration on admission and mortality in patients with massive transfusion after severe trauma: an analysis of a large regional database.","volume":"26","author":"Bouzat","year":"2018","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"2","key":"joi230034r21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00068-019-01165-7","article-title":"Diagnostic performance of thromboelastometry in trauma-induced coagulopathy: a comparison between two level I trauma centres using two different devices.","volume":"47","author":"Bouzat","year":"2021","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"11","key":"joi230034r23","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s00134-022-06834-7","article-title":"Trauma-induced coagulopathy.","volume":"48","author":"Kleinveld","year":"2022","journal-title":"Intensive Care Med"},{"issue":"12","key":"joi230034r24","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1111\/j.1537-2995.2009.02335.x","article-title":"Thrombin generation in trauma patients.","volume":"49","author":"Dunbar","year":"2009","journal-title":"Transfusion"},{"issue":"2","key":"joi230034r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.5085","article-title":"Association of prehospital plasma transfusion with survival in trauma patients with hemorrhagic shock when transport times are longer than 20 minutes: a post hoc analysis of the PAMPer and COMBAT clinical trials.","volume":"155","author":"Pusateri","year":"2020","journal-title":"JAMA Surg"},{"issue":"3","key":"joi230034r26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/bja\/aen391","article-title":"Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model.","volume":"102","author":"Dickneite","year":"2009","journal-title":"Br J Anaesth"},{"issue":"10","key":"joi230034r27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258192","article-title":"Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models.","volume":"16","author":"Ghosh","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"joi230034r28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-059181","article-title":"Quality evaluation of clinical practice guidelines for thromboprophylaxis in orthopaedic trauma based on AGREE II and AGREE-REX: a systematic review protocol.","volume":"12","author":"He","year":"2022","journal-title":"BMJ Open"},{"issue":"11","key":"joi230034r29","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamasurg.2019.2884","article-title":"Effect of low-dose supplementation of arginine vasopressin on need for blood product transfusions in patients with trauma and hemorrhagic shock: a randomized clinical trial.","volume":"154","author":"Sims","year":"2019","journal-title":"JAMA Surg"},{"key":"joi230034r22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cphy.c170006","volume-title":"Comprehensive Physiology","author":"Torres Filho","year":"2017"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2802855\/jama_bouzat_2023_oi_230034_1681934420.53211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T11:49:47Z","timestamp":1682423387000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2802855"}},"subtitle":["The PROCOAG Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":29,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023,4,25]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.4080","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}